Rethinking Opioid Conversions: Mary Lynn McPherson and Drew Rosielle
GeriPal
MAY 19, 2022
I think part of it’s the math, but I think what really happened is, I think the story here is that in 2018, MD Anderson published this really landmark study by Dr. Reddy and her colleagues about going from IV Dilaudid to other to oral Dilaudid, oral hydromorphone, I should say, oral morphine and oral oxycodone. Drew: I agree in part.
139 
Let's personalize your content